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Vitamin B12 is known to play critical roles during the
development and aging of the brain, and vitamin B12
deficiency has been linked to neurodevelopmental
and degenerative disorders. However, the underlying
molecular mechanisms of how vitamin B12 affects
the development and maintenance of the nervous
system are still unclear. Here, we report that vitamin
B12 can regulate glial migration and synapse forma-
tion through control of isoform-specific expression
of PTP-3/LAR PRTP (leukocyte-common antigen-
related receptor-type tyrosine-protein phosphatase).
We found the uptake of diet-supplied vitamin B12 in
the intestine to be critical for the expression of a long
isoform of PTP-3 (PTP-3A) in neuronal and glial cells.
The expression of PTP-3A cell autonomously regu-
lates glial migration and synapse formation through
interaction with an extracellular matrix protein NID-
1/nidogen 1. Together, our findings demonstrate
that isoform-specific regulation of PTP-3/ LAR
PRTP expression is a key molecular mechanism
that mediates vitamin-B12-dependent neuronal and
glial development.
INTRODUCTION
Vitamin B12 deficiency has long been associated with a range of
neurological complications, including neurodevelopmental dis-
orders, subacute combined degeneration, behavioral changes,
and cognitive decline (Black, 2008; Douaud et al., 2013; Healton
et al., 1991; Lindenbaum et al., 1988; Reynolds, 2006). Vitamin
B12 functions as a coenzyme in two important biochemical reac-
tions that both may be relevant to the symptoms. The first is dur-
ing the conversion methylmalonyl coenzyme A (CoA) to succinyl
CoA, which is important for fatty acid metabolism, and reduced
function may lead to incorporation of abnormal odd-numbered
and branched fatty acids into the myelin, resulting in increased
fragility (Cardinale et al., 1970; Dror and Allen, 2008; Green and
Kinsella, 1995; Stollhoff and Schulte, 1987). The other reactionCell R
This is an open access article under the CC BY-Nmediated by vitamin B12 is the conversion of homocysteine
into methionine. This is important for the generation of S-adeno-
sylmethionine, a methyl donor important for the methylation of
DNA and the synthesis of lipids, proteins, and neurotransmitters
in the nervous system (Briddon, 2003; Dror and Allen, 2008;
Green et al., 2017; Reynolds, 2006). Although the coenzyme
function of vitamin B12 has been well documented in the devel-
opment and aging of the brain, other studies have also high-
lighted potential non-coenzyme functions of vitamin B12 in the
nervous system (Scalabrino, 2009; Scalabrino et al., 1995), and
there is still much to know about whether and how vitamin B12
affects the nervous system through its non-coenzyme functions.
Glial cells perform a wide range of vital roles in the nervous
system, ranging from modulating development to actively play-
ing a role in neuronal function (Barres, 2008; Fields et al., 2015;
Mori et al., 2005). They need to migrate over what are often
long distances from their birthplace to the appropriate regions
to form functional units with neurons or perform other roles (Gil-
mour et al., 2002; Jarjour and Kennedy, 2004; Kinrade et al.,
2001; Klämbt, 2009). The migration of glial cells can be divided
into three steps: initiation; movement; and termination. Guidance
molecules, including those from the netrin, slit, and semaphorin
families can initiate and direct themovement of glial cells through
interactions with their receptors that they express (Jarjour et al.,
2003; Kinrade et al., 2001; Sasse and Klämbt, 2016; Spassky
et al., 2002; Unni et al., 2012). However, it is still unclear what
controls the termination of migration after glial cells reach their
final positions.
C. elegans possess 56 glial cells in their body, which include 50
neuroepithelial glia that ensheath sensory neuron receptive end-
ings (Oikonomou and Shaham, 2011; Shaham, 2015). The
largest sensory organ of the worm, called the amphid sensilla,
is a pair of sensilla composed of 12 neurons and 2 glial cells
each (Ward et al., 1975). These glia, called the amphid sheath
(AMsh) and amphid socket (AMso) cells, form channels that en-
sheath the dendrites of sensory neurons in the amphid sensilla
(Oikonomou and Shaham, 2011; Perkins et al., 1986; Ward
et al., 1975). Furthermore, these glial cells are vital for the proper
functioning of the neurons that they ensheath, where they can
modulate neural activity through secreted molecules at the
receptive endings and control neuron receptive ending shape







































































































































Figure 1. Vitamin B12 Is Required for Terminating Glial Migration
(A) yad138 causes over-migration of AMsh glia. Confocal images and sche-
matic representation of AMsh glia in control and mrp-5(yad138) animals
expressing Pf53f4.13::GFP (yadIs48) are shown. TB, pharyngeal terminal bulb.
Scale bar, 10 mm.
(B) Quantification of Migration Index (MI) in control andmrp-5(yad138) animals.
MI is calculated as (b  a)/a 3 100%. As illustrated in (A), ‘‘a’’ represents the
distance between the tip of nose and the center of the pharyngeal terminal
bulb. ‘‘b’’ shows the distance between the tip of nose and the center of the
AMsh cell bodies.
(C)mrp-5 functions in the intestine to regulate Amsh migration. White and gray
bars show the percentage of animals with over-migration defects in one AMsh
or both AMsh glia, respectively. Pvha-6 is an intestine-specific promoter,
Pf53f4.13 drives expression only in AMsh glia, and Pmyo-2 is a pharyngeal-
muscle-specific promoter.
(D) Injection of vitamin B12, but not heme, rescues mrp-5(lf) phenotypes.
(E) A schematic showing how vitamin B12 deficiency was induced.
(F) Quantification of MI of AMsh glia in animals cultured in control and vitamin-
B12-deficient conditions.
(G) Dietary supplementation of vitamin B12, but not heme, rescued AMsh
migration defects in vitamin-B12-deficient conditions. Data show the
percentage of animals with AMsh migration defects.
In (B) and (F), data are represented as mean ± SEM. One-way ANOVA test;
**p < 0.01; each point represents at least 30 worms. In (C), (D), and (G), data are
represented as mean ± SEM. Two-way ANOVA test; **p < 0.01; ns, no
significant difference. Each point represents three experiments of at least 50
worms each.Here, we describe a function of vitamin B12 in the regulation of
glial migration and synapse formation. We found that either die-
tary vitamin B12 deficiency or reduced uptake in the intestine3982 Cell Reports 30, 3981–3988, March 24, 2020due to a mutation in the ABC transportermrp-5 (multidrug resis-
tance protein 5) leads to an over-migration of AMsh glia. Further-
more, vitamin B12 functions during glial migration and synapse
formation by regulating the expression of the protein tyrosine
phosphatase PTP-3/LAR PRTP in an isoform-specific manner.
PTP-3A interacts with the extracellular matrix protein NID-1/ni-
dogen 1 near the pharynx to regulate glial migration. Our findings
reveal a vitamin-B12-dependent pathway regulating both glial
and neuronal development that may inform our understanding
of neuropathies derived from vitamin B12 deficiency.
RESULTS
To study mechanisms regulating glial migration, we used
C. elegans AMsh glial cells as a model. AMsh glia are born close
to the nose of C. elegans and then their processes anchor to the
surface of embryos while the cell bodies migrate toward the
nerve ring (Heiman and Shaham, 2009). In day 1 (D1) young
adults, AMsh cell bodies reside at the side of and align with the
center of pharyngeal terminal bulbs (Figures 1A and 1B). In a
genetic screen, we isolated a mutant yad138, whose AMsh cell
body positions were indistinguishable from those of control ani-
mals in L1 larvae but possess AMsh cell bodies that fail to stop at
the pharyngeal terminal bulbs andmigrate further down the body
in D1 adults (Figures 1A, 1B, and S1A–S1C). To further confirm
these observations, we visualized single animals at different
developmental stages and found all mutants examined in this
study have similar AMsh cell body positions at the L1 stage
when compared to control animals, but their AMsh cell bodies
migrate further down the body and fail to stop at the correct
place in the L4 and adult stages (Figure S1D). These results sug-
gest that yad138 likely affects a molecule involved in terminating
AMsh migration. yad138 causes a missense mutation in the
C. elegans ABC transporter mrp-5, which has been shown to
play essential roles in the export of vitamin B12 and heme from
the intestine to other tissues (Korolnek et al., 2014; Na et al.,
2018; Figure S1E). We found that driving expression of mrp-5
by its own promoter or an intestine-specific promoter was able
to fully rescue yad138 phenotypes, although expression of
mrp-5 in AMsh glia or pharyngeal muscles did not change the
phenotypes (Figure 1C). These results show that yad138 is a
loss-of-function allele ofmrp-5, andmrp-5 functions in the intes-
tine to affect AMsh migration.
To determine whether the role ofmrp-5 in AMsh glial migration
is related to its function in the uptake of vitamin B12 or heme in
the intestine, we directly injected vitamin B12 or heme to mrp-
5(yad138) L1 larvae and observed full rescue of AMsh migration
defects in vitamin B12-injected, but not heme-injected, animals
(Figure 1D). Vitamin B12 also appears to function during early
developmental stages, as injection of the same concentration
of vitamin B12 in L4 larvae did not show any rescue ability on
mrp-5(yad138) animals when they were scored as D1 adults
(Figure 1D). To further confirm the importance of vitamin B12 in
regulating AMsh glial migration, we cultured control animals in
vitamin-B12-deficient conditions as outlined by Bito et al.
(2013); Figure 1E. Similar to what they reported, we observed a
reduction in brood size when animals were grown for five gener-































































































































Figure 2. ptp-3a Functions in the Same Ge-
netic Pathway as mrp-5 and Vitamin B12 in
Regulating Glial Migration
(A) Quantification of MI in control, ptp-3a(yad120),
and ptp-3a,b(yad121) animals.
(B) ptp-3a, but not ptp-3b, regulates AMsh migra-
tion. White and gray bars show the percentage of
animals with over-migration defects in one AMsh or
both AMsh glia, respectively. Pf53f4.13 drives
expression only in AMsh glia.
(C andD) Doublemutants of ptp-3a;mrp-5 and ptp-
3a;cubn-1 display similar defects as in ptp-3a
single mutants. Quantification of MI of AMsh glia
(C) and the percentage of animals with over-
migration defects (D) are shown.
In (A) and (C), data are represented as mean ±
SEM. One-way ANOVA test; **p < 0.01; each point
represents at least 30 worms. In (B) and (D), data
are represented as mean ± SEM. Two-way ANOVA
test; **p < 0.01; each point represents three
experiments of at least 50 worms each.Figure S1F). Vitamin-B12-deficient animals displayed similar
AMsh migration defects as those observed in mrp-5 mutants
(Figure 1F). Dietary supplementation of vitamin B12, but
not heme, was able to prevent the AMsh migration defects
observed in vitamin-B12-deficient conditions (Figure 1G). We
also found that feeding animals a vitamin-B12-enriched diet
did not cause any observable abnormalities in AMsh develop-
ment (Figure S1G).
In the same genetic screen, we isolated other mutants with
similar phenotypes as those in mrp-5 mutants, and further ana-
lyses showed that two of them, yad122 and yad139, belong to
a same complementation group and both affect cubn-1 (Figures
S2A–S2D), the only C. elegans homolog of the intrinsic factor-
vitamin B12 receptor cubilin (Kozyraki et al., 1998; Seetharam
et al., 1997). Expression of cubn-1 under its own promoter fully
rescued yad122 phenotypes, and yad122 exhibits a similar
degree of AMsh migration defects as presumed null alleles
(Figure S2C). These results support the conclusion that yad122
and yad139 are loss-of-function alleles of cubn-1, and yad122
is likely a null allele. Cubilin is a giant secreted protein and func-
tions together with a receptor called megalin to uptake intrinsic
factor-vitamin B12 (Ahuja et al., 2008; Moestrup et al., 1998;
Nielsen et al., 2016). To understand how cubn-1 affects AMsh
migration, we examined the function of C. elegans megalin lrp-
1, and the results showed that knockdown of lrp-1 caused a
similar degree of AMsh migration defects as was found in
cubn-1 mutants, but knockdown of lrp-1 in a cubn-1(lf) back-
ground did not further enhance cubn-1 mutant phenotypesCell Re(Figures S3A–S3C). These results suggest
that the function of cubn-1 likely relies on
its binding with lrp-1 to uptake vitamin
B12, similar to what was previously re-
ported in mammalian systems (Ahuja
et al., 2008; Moestrup et al., 1998; Nielsen
et al., 2016). Further experiments showed
that knockdown of lrp-1 expression only
in AMsh glia caused the same degree ofmigration defects as those in global knockdown animals (Fig-
ure S3C), suggesting lrp-1 cell autonomously regulates AMsh
migration. We also found that double mutants of cubn-1;mrp-5
exhibited similar defects as those in mrp-5 single mutants, and
knockdown of lrp-1 did not further enhance mrp-5 mutant
phenotypes (Figures S3D–S3F). These results suggest that
CUBN-1 and LRP-1 likely function as co-receptors in AMsh
glia to uptake vitamin B complex into AMsh glia to terminate
AMsh migration. Taken together, these results demonstrate the
important role of vitamin B12 in regulating glial migration. To
understand how vitamin B12 regulates AMsh migration, we
tested three important enzymes involved in C. elegans vitamin-
B12-dependent metabolic pathways—pcca-1/propionyl-CoA
carboxylase alpha chain,mmcm-1/methylmalonyl-CoA mutase,
and metr-1/5-methyltetrahydrofolate-homocysteine methyl-
transferase (Watson et al., 2014), but we did not notice any ab-
normalities in AMsh migration in loss-of-function mutants of
these three genes (Figure S3G), suggesting that vitamin B12
may regulate AMsh glial migration through other means.
To further illuminate the molecular mechanisms underlying
AMshmigrationmediated by vitamin B12, we analyzed two other
mutants with AMsh over-migration defects that were isolated in
the initial screen, yad120 and yad121 (Figures 2A, 2B, and S1A).
They failed to complement each other, and both alter the
C. elegans homolog of LAR PRTP (leukocyte-common antigen-
related receptor-type tyrosine-protein phosphatase) ptp-3
(Figure S4A). Interestingly, yad120 has stronger defects than














































































































































































































Figure 3. mrp-5 and Vitamin B12 Regulates
AMsh Migration through Isoform-Specific
Control of ptp-3a, but Not ptp-3b, Expres-
sion
(A–C) Loss of function inmrp-5 decreases PTP-3A,
but not PTP-3B, protein levels. Confocal images (A,
left panel, GFP; right panel, differential interference
contrast [DIC] merged with GFP; scale bar, 10 mm)
and quantification (B and C) show the expression
level of PTP-3A and PTP-3B in control andmrp-5(lf)
animals. The red arrowheads point to AMsh cell
bodies.
(D–F) Vitamin B12 deficiency suppresses PTP-3A,
but not PTP-3B, expression. Confocal images (D,
left panel, GFP; right panel, DIC merged with GFP;
scale bar, 10 mm) and quantification (E and F) show
the expression level of PTP-3A and PTP-3B in
control vitamin-B12-deficient and vitamin-B12-
supplemented conditions.
(G and H) Real-time PCR results show that loss of
function in mrp- 5 (G) or culturing animals in
vitamin-B12-deficient conditions (H) decrease ptp-
3a mRNA levels. A housekeeping gene, cdc-42,
was used as an internal control.
(I) Overexpression of ptp-3a, but not ptp-3b, in
AMsh cells suppresses migration defects in mrp-
5(lf) mutants.
(J) Overexpression of ptp-3a, but not ptp-3b, in
AMsh cells suppresses migration defects caused
by vitamin B12 deficiency.
In (B), (C), (E), and (F), data are represented as
mean ± SEM. One-way ANOVA test; **p < 0.01;
each point represents at least 20 worms. In (G)–(H),
data are represented as mean ± SEM. One-way
ANOVA test; **p < 0.01; each point represents
three experimental replicates. In (I)–(J), data are
represented as mean ± SEM. Two-way ANOVA
test; **p < 0.01; each point represents three ex-
periments of at least 50 worms each.yad121 affects both long and short isoforms ptp-3a and ptp-3b
(Figures 2A, 2B, and S4A). Like what we observed in mrp-5
mutants, loss of function of ptp-3 did not affect the position of
AMsh cells in L1 larvae, suggesting that it may play a role in ter-
minating glial migration (Figure S1B). The two isoforms ptp-3a
and ptp-3b have been shown to play distinct functions in syn-
apse formation, axon guidance, and neuronal migration (Ackley
et al., 2005; Sundararajan and Lundquist, 2012). To determine
whether both isoforms are important for AMsh migration, we
carried out rescue experiments and found that expression of
ptp-3a under either its own promoter or an AMsh-specific pro-
moter was able to fully rescue yad121 phenotypes, although
expression of ptp-3b did not show any rescue ability (Figure 2B).
Similar results were obtained from yad120 rescue experiments
that ptp-3a, but not ptp-3b, can rescue AMsh migration defects
(Figure 2B). We also examined a null allele of ptp-3a(ok244) and
showed that it had the same degree of AMsh migration defects3984 Cell Reports 30, 3981–3988, March 24, 2020as observed in yad120 (Figure 2B). Using
both transcription and translational re-
porters, we confirmed that ptp-3a is ex-
pressed in AMsh glial cells (Figures S4Band S4C). These results support the conclusion that ptp-3a,
but not ptp-3b, cell autonomously regulates AMsh migration.
Because both mrp-5(lf), cubn-1(lf), and ptp-3a(lf) cause over-
migration of AMsh glia, we decided to test whether they might
function in the same genetic pathway, and we found that double
mutantsofmrp-5;ptp-3aandcubn-1;ptp-3a showedasimilar de-
gree of phenotypes as was found in ptp-3a single mutants, sup-
porting the conclusion that ptp-3a likely lies in the same pathway
asmrp-5 and cubn-1 (Figures 2C, 2D, and S4D). Because ptp-3a
functions in AMsh cells to affect migration, it is possible that its
expression or functions are regulated by mrp-5 through vitamin
B12. To test this hypothesis, we first examined whether loss of
function ofmrp-5mayaffectptp-3a expression or localization us-
ing a well-established ptp-3a translation reporter (Ackley et al.,
2005). As shown in Figure 3A, in control animals, we observed
puncta expression of PTP-3A in the nerve ring as well as in
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Figure 4. Vitamin B12 and mrp-5 Regulate
Synapse Formation through ptp-3a, and
the Interactions of nid-1 with ptp-3a Play
an Important Role in Both Synapse Forma-
tion and Glial Migration
(A and B) mrp-5 regulates synapse formation
through vitamin B12 and ptp-3a. Confocal images
(A) show GABA neuron synapses visualized by
SNB-1::GFP (juIs1) at the dorsal cord (scale bar,
10 mm), and quantification data (B) show the total
SNB-1::GFP puncta number in the dorsal cord.
(C and D) Vitamin B12 regulates synapse formation
through ptp-3a. Confocal images (C) show GABA
neuron synapses visualized by SNB-1::GFP (juIs1)
at the dorsal cord (scale bar, 10 mm), and quanti-
fication data (D) show the total SNB-1::GFP puncta
number in the dorsal cord.
(E and F) nid-1 functions together with ptp-3a to
regulate AMsh migration.
(E) Quantification of MI in control, nid-1, ptp-
3a(yad120), and nid-1;ptp-3a(yad120) animals.
(F) The percentage of animals with over-migration
defects. Pmyo-2 is a pharyngeal-muscle-specific
promoter.
In (B), (D), and (E), data are represented as mean ±
SEM. One-way ANOVA test; **p < 0.01; each point
represents at least 20 worms. In (F), data are rep-
resented as mean ± SEM. Two-way ANOVA test;
**p < 0.01; each point represents three experi-
ments of at least 50 worms each.expression of PTP-3A to less than 30% of that in control, and the
PTP-3Aexpression reporter becomes invisible in theAMshglia of
mrp-5 mutants (Figures 3A and 3B). In contrast, mutations of
mrp-5 did not alter PTP-3B expression (Figures 3A and 3C).
Consistent with the observations inmrp-5(lf) animals, we showed
that animals cultured in vitamin-B12-deficient conditions ex-
hibited a similar decrease of PTP-3A expression, although the
expression of PTP-3B was comparable to that in control condi-
tions (Figures 3D–3F). The regulation of ptp-3a expression by
mrp-5 and vitamin B12 has also been confirmed on the mRNA
level by real-timePCR (Figures3Gand3H). These results suggest
that the uptake of vitamin B12 mediated by mrp-5 may regulate
AMshmigration through transcriptional control of ptp-3a expres-
sion in AMsh cells. To further confirm this conclusion, we overex-
pressed ptp-3a or ptp-3b only in AMsh cells and tested whether
those transgenes were able to bypass the requirement of mrp-5
in the termination of AMsh migration. In support of our hypothe-
sis, overexpression of ptp-3a, but not ptp-3b, in AMsh glia nearly
completely suppressed AMsh migration defects in mrp-5 mu-Cell Retants (Figures 3I and S4E). We also found
that overexpression of ptp-3a, but not
ptp-3b, was able to eliminate the AMsh
migration defects caused by vitamin B12
deficiency (Figure 3J). In conclusion, these
results demonstrate that the uptake of
vitamin B12 from the diet mediated by
mrp-5 in the intestine can control the
expression level of ptp-3a, and the
expression of ptp-3a in AMsh glia has acritical role in terminating cell migration at the appropriate place.
As AMsh glia are essential for the function of sensory neurons
they ensheath, we used the classic dye filling assay to examine
whether the AMsh migration defects we described in this study
could affect sensory neuron function (Oikonomou and Shaham,
2011; Shaham, 2015). We found that neither mrp-5(lf) nor ptp-
3a(lf) caused dye filling defects in D1 young adults (Figure S4F).
However, we observed a significant reduction in the number of
neurons that uptake Dil in D7 mrp-5(lf) and ptp-3a(lf) animals
when compared with the same age control animals (Figure S4G).
The dye filling defects displayed in aged mrp-5(lf) and ptp-3a(lf)
animals were caused by abnormal migration of AMsh, as expres-
sion of ptp-3a only in AMsh glia could fully rescue their dye filling
defects (Figure S4G). Taken together, these results suggest that
the correct localization of AMsh cell bodies is critical formaintain-
ing the function of sensory neurons they ensheath during aging.
Becauseptp-3aplays a critical role in regulating synapse forma-
tion (Ackleyet al., 2005),we testedwhethermrp-5 and vitaminB12
have a role in synapse formation as well. As shown in Figures 4Aports 30, 3981–3988, March 24, 2020 3985
and 4B, loss of function ofmrp-5 caused enlarged synapses and
decreased synapse number, similar to what has been shown in
ptp-3a mutants. mrp-5(lf) phenotypes were caused by defects in
vitamin B12 uptake, as injection of vitamin B12 was able to
completely rescue mrp-5(lf) phenotypes (Figures 4A and 4B). We
also found that overexpression of ptp-3a can cell autonomously
suppress mrp-5(lf) defects, supporting the conclusion that lack
of vitaminB12causedbyamutant formofmrp-5disrupts synapse
formation through downregulating ptp-3a expression. We further
confirmed this by showing that culturing animals in vitamin-B12-
deficient conditions caused similar synapse formation defects as
those displayed inmrp-5(lf) or ptp-3a(lf) animals, and overexpres-
sion of ptp-3a prevented synapse formation defects caused by
vitamin B12 deficiency (Figures 4C and 4D).
In synapse formation, PTP-3A functions through interactions
with an extracellular matrix protein NID-1, an ortholog of hu-
man nidogen 1 and nidogen 2 (Ackley et al., 2005). We found
that loss of function of nid-1 caused AMsh over-migration de-
fects, and double mutants of nid-1;ptp-3a exhibited a similar
degree of defects as those found in ptp-3a single mutants
(Figures 4E, 4F, and S1A–S1D), confirming that nid-1 is likely
also a functional partner of ptp-3a in regulating glial migration.
More interestingly, expression of nid-1 only in the pharyngeal
muscle was able to fully rescue nid-1(lf) phenotypes, which
is consistent with the strong expression of nid-1 in the phar-
ynx, as previously shown (Figure 4F; Ackley et al., 2005;
Kang and Kramer, 2000). Expression of NID-1::GFP suggested
potential accumulation of NID-1 on the surface of AMsh cell
bodies (Figure S4H). Therefore, it is likely that the interactions
between AMsh-expressed PTP-3A and pharynx-expressed
NID-1 provide the signals to terminate AMsh migration at the
pharyngeal terminal bulbs. In conclusion, our study provides
a common mechanism for regulation of both neuronal and glial
development by vitamin B12, in which the uptake of vitamin
B12 by the intestine can regulate the expression of PTP-3 in
an isoform-specific manner, and this regulation also relies on
the interactions between PTP-3 and the extracellular matrix
protein NID-1 (Figure S5).
DISCUSSION
In our study, we uncover a role of vitamin B12 in glial migration
and synapse formation, and we show that vitamin B12 functions
by regulating the expression of ptp-3a, the C. elegans homolog
of mammalian LAR PRTP. C. elegans ptp-3a and mammalian
LAR PRTPs are highly expressed in the nervous system and
have been shown to be important for synapse formation, axon
development, and axon regeneration in neurons (Ackley et al.,
2005; Chagnon et al., 2004; Chen et al., 2011; Stoker, 2015; Ta-
kahashi and Craig, 2013). Our findings further reveal a function of
LAR PRTPs in regulating glial migration and show ptp-3a/LAR
PRTP expression to be connected to vitamin B12 uptake in the
intestine. As vitamin B12 deficiency causes many neurodevelop-
mental and degenerative disorders that are associated with
abnormality in both neurons and glial cells (Cardinale et al.,
1970; Douaud et al., 2013; Healton et al., 1991; Reynolds,
2006; Scalabrino et al., 1995; Stollhoff and Schulte, 1987), it is
possible that ptp-3a/LAR PRTP as a target for vitamin B12 is3986 Cell Reports 30, 3981–3988, March 24, 2020associated with multiple neurological symptoms of vitamin B12
deficiency.
Besides the nervous system, LAR PRTPs are also expressed
in a wide range of cell types, including T lymphocytes, kidney
cells, prostate cells, and intestinal epithelial cells (Murphy
et al., 2005; Pulido et al., 1995; Streuli et al., 1988) and are known
to be involved in the regulation of insulin signaling, epithelial
integrity, and cancer progression (Mooney and LeVea, 2003;
M€uller et al., 1999; Murchie et al., 2014; Xu and Fisher, 2012).
Furthermore, mutations in LAR PRTPs have been linked to hy-
perinsulinism and obesity in human patients (Alliance of Genome
Resources). A major symptom of vitamin B12 deficiency is
anemia, which may or may not coincide with neurological symp-
toms (Green et al., 2017; Lindenbaum et al., 1988; Reynolds,
2006). Other symptoms may include fatigue, decreased
appetite, glossitis, and reduced gastrointestinal function (Briani
et al., 2013; Green et al., 2017; Hunt et al., 2014). As some of
these symptoms appear to relate to either insulin signaling or
epithelial integrity, where LAR PRTPs are known to play impor-
tant roles, the regulation of ptp-3a by vitamin B12 may also be
relevant.
In this study, we found that vitamin B12 controls glial migration
and synapse formation through regulating ptp-3a transcription.
However, the question of how this regulation happens is still un-
clear. Different levels of vitamin B12/folic acid have been shown
to affect specific DNA methylation patterns, and maternal
vitamin B12/folic acid levels during pregnancy were also shown
to affect DNA methylation patterns in infants (Hoyo et al., 2011;
Kok et al., 2015; McKay et al., 2012; Rampersaud et al., 2000).
In our experiments, we found that injection of vitamin B12 at
the early, but not late, larval stages is sufficient for normal glial
and neuronal development, suggesting that this regulation of
ptp-3a by vitamin B12 occurs during early developmental
stages. Therefore, one possibility is that, during development,
vitamin B12 can affect the methylation of DNA in the regulatory
elements of the ptp-3a promoter to facilitate its transcription. A
second possibility is that vitamin B12 may regulate ptp-3a on
the mRNA level, as previous studies show that vitamin B12 can
bind to regulatory elements of messenger RNAs to control
gene expression (Mandal and Breaker, 2004; Nahvi et al.,
2004; Padmanabhan et al., 2017). It is also possible that vitamin
B12 may regulate the expression or activation of certain tran-
scription factors that are important for ptp-3a expression.
Further studies are needed to uncover the detailed mechanism
of how vitamin B12 regulates ptp-3a transcription.STAR+METHODS
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duke.edu). C. elegans strains and plasmids generated in this study are available from the lead contact without restriction.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
C. elegans genetics
C. elegans strains were maintained on nematode growthmedia (NGM) plates using E. coliOP50 as a food source. Animals were grown
according to standard methods (Brenner, 1974) at 20C unless otherwise stated. Wild-type worms were of the Bristol N2 strain. OnlyCell Reports 30, 3981–3988.e1–e3, March 24, 2020 e1
hermaphrodite animals were used for experiments. All transgenes and strains are described in Table S1. yadIs48 (Pf53f4.13::GFP) was
used to visualize AMsh cells. juIs1 (Punc-25::SNB-1::GFP) was used to visualize GABA synapses. The alleles used in genetic analyses
weremrp-5(yad138), cubn-1(yad122), ptp-3a(yad120), and nid-1(cg119) unless specific alleles were mentioned.
METHOD DETAILS
Cloning and constructs
All DNA expression constructs were generated using Gateway cloning technology (Invitrogen, Carlsbad, CA) and subsequently
sequenced. mrp-5 and nid-1 were amplified from a homemade genomic pool. A 2kb fragment before the start codon of mrp-5
was used as its promoter. A 2.5 kb fragment before the start codon of nid-1 was used as its promoter. A complete list of DNA
constructs used is included in Table S1. In general, plasmid and PCR DNA used in this study were injected at a concentration of
1-50ng/mL with a Pttx-3::RFP co-injection marker injected at a concentration of 50ng/mL.
RNA Interference
RNA interference (RNAi) experiments were carried out by feeding anaimls with E. coli strain HT115 (DE3) expressing double-stranded
RNA against target genes for at least two generations. All lrp-1 RNAi clones were made by inserting 1kb cDNA fragments into the
L4440 vector. RNAi clones were first cultured overnight using LB broth containing ampicillin (100 mg/ml) at 37C, and then concen-
trated bacteria were seeded on NGMplates containing 100mg/ml ampicillin and 5mM isopropyl 1-thio-b-D-galactopyranoside (IPTG)
and cultured overnight at 37C. Animals were grown on RNAi plates for at least two generations. In all experiments, either GFP RNAi
or unc-22 RNAi was included as a control to account for RNAi efficiency. Tissue-specific RNAi was carrired out as described (Calixto
et al., 2010; Feinberg and Hunter, 2003). In brief, to knock down gene expression only in pharyngeal muscles, we expressed the
sid-1(cDNA) under the control of the Pf53f4.13 promoter, a AMsh specific promoter in an sid-1(pk3321) mutant background. sid-1
mutants are resistant to RNAi, and transgenic animals (yadEx760;sid- 1(pk3321)) are resistant to RNAi in all tissues except in the
AMsh glial cells which express sid-1 cDNA.
Microscopy
Representative images were acquired with a Zeiss LSM700 confocal microscope using a Plan-Apochromat 40x/1.4 objective.
Worms were immobilized using 1.5% 1-phenoxy-2-propanol (TCI America, Portland, OR) in M9 buffer and mounted on 5% agar
slides. 3D reconstructions were done using Zeiss Zen software. Images of GABA neuron synapses show the dorsal cord at themiddle
part of animals. A Zeiss Axio Imager 2 microscope equipped with Chroma HQ filters was used to score AMsh migration defects and
take images to measure Migration Index. For GABA neuron synapse number quantification, a Zeiss Axio Imager 2 microscope
equipped with Chroma HQ filters was used to quantify the total number of SNB-1::GFP puncta at the dorsal cord. Each condition
represented 3 experiments of at least 50 Day 1 adult animals each unless otherwise noted.
Brood size assays
Brood size assays were performed by allowing gravid adults to lay eggs for 3 days on plates seeded with vitamin B12-deficient OP50
before the adults were removed. One day later, the total number of embryos or hatched animals were counted. Three experiments of
at least 20 animals were quantified for each condition.
Vitamin B12 deficiency assays
Vitamin B12 deficiency assays were performed as previously described (Bito et al., 2013). In brief, vitamin B12-deficient OP 50 was
cultured as a food source: OP50 was grown in M9medium at 37C for 3 days. Animals were then cultured using M9 agar (2%) plates
seeded with the vitamin B12-deficient OP50 as their food source. All animals were grown in this condition for five generations with or
without vitamin B12 (cyanocobalamin) (Sigma) (100 mg/L) or heme (Sigma) (500 mM) dietary supplementation.
Vitamin B12/heme injection
Vitamin B12 (3.2 mM) or heme (500 mM) were prepared using autoclaved water and were injected into the middle part of animals. We
followed the standard protocol for all injections. For L1 injections, we cultured newly hatched animals in 20C for 12 hours to reach the
late L1 stage. The injection was performed by placing animals on 10% agar pads, which were newly made and air-dried for 30-
45 mins, with lower injection air pressure (1/3 of pressure for L4 animal injection). The L1 injection needle tips also had to be thinner
than regular L4 injection ones. When injections were performed in L1 animals, about 40%–60% animals failed to recover, and all data
were collected from day 1 adults. Injected L4 animals had over a 90% recovery rate, and data were also collected in day 1 adults
Dye filling
Dil is purchased from Molecular Probes (Eugene, OR), and the stock solution is 2 mg/ml in dimethylformamide. We performed the
experiments following the standard protocol. In brief, D1 and D7 adult animals were collected and washed three times in M9 buffer,
and then incubated in 10 ng/ml Dil solution (in M9) for 2 hours at 20C. After 2 hours incubation with Dil solution, animals were washed
3 times (20 min/each) in M9 buffer before visualization using 63X lens.e2 Cell Reports 30, 3981–3988.e1–e3, March 24, 2020
Real-time Reverse Transcription PCR
To measure changes in ptp-3a mRNA levels in mrp-5 mutants and N2 animals with or without vitamin B12, total RNA was isolated
frommixed population plates. Animals were washed withM9 buffer three times for 90minutes in total, and TRI Reagent (Invitrogen)
was subsequently added to isolate the RNA. Animals were independently cultured and collected three times for each condition.
Reverse transcription was performed on total RNA (1 mg) using an iScript Reverse Transcription Supermix for RT-qPCR (Bio-Rad
Laboratories). Quantitative real-time, reverse-transcription PCR (qPCR) was performed using iTaq Universal Probes Supermix
(Bio-Rad Laboratories) and ready-to-use TaqMan Gene Expression Assays (Invitrogen), and mRNA levels of ptp-3a and cdc-42
were quantified, with cdc-42/cell division control protein 42 serving as an internal control. qPCR amplifications were performed using
an Applied Biosystems StepOnePlus Real-Time PCR System (Applied Biosystems). Relative mRNA levels were quantified using the
StepOnePlus Software v2.1 based on the comparative DDCT method.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis
Data was analyzed using one-way or two-way ANOVA followed by Tukey’s post hoc test in Graphpad Prism (Graphpad Software, La
Jolla, CA). Statistical details are included in the figure legends. In general, a p value cutoff of 0.05 was considered statistically
significant. The data are represented by mean ± SEM. For phenotype penetrance experiments, three biological replicates of at least
50 animals each were used unless otherwise stated.
DATA AND CODE AVAILABILITY
This study did not generate any unique datasets or code.Cell Reports 30, 3981–3988.e1–e3, March 24, 2020 e3
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Supplemental Figure 1, Vitamin B12 is critical for AMsh glial migration. 
Related to Figures 1, 2 and 4.
(A) Data showing the relative distance between the nose tip and the center of the pharyngeal terminal bulb (TB) in control and mutant D1 
animals. Data are normalized by the average distance between the nose tip and the center of the TB in control animals. 
(B) Data showing the relative distance between the nose tip and the center of AMsh cell bodies in control and mutant D1 animals. Data are 
normalized by the average distance between the nose tip and the center of the AMsh cell bodies in control animals. 
(C) Data showing the Migration Index of control and mutant animals at the L1 stage. 
(D) Data showing the distance between the nose tip and the center of AMsh cell bodies at different developmental stages of individual 
animals. Five animals were quantified for each genotype, and each animal is represented by a single line. 
(E) yad138 caused a missense mutation in mrp-5. 
(F) Data showing the brood size of animals grown in vitamin B12-deficient conditions for five generations with/without vitamin B12 or 
heme supplementation. 
(G) Data showing the percentage of animals with AMsh migration defects when fed a vitamin B12 enriched diet either by feeding the E. coli 
In Figs. A, B, C, and F, data are represented as mean ± SEM. One-way ANOVA test. **, P<0.01; ns, no significant difference. Each point 
represents at least 20 worms. In Fig. G, data are represented as mean ± SEM. Two-way ANOVA test. **, P<0.01; ns, no significant 
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Supplemental Figure 2, cubn-1 functions in AMsh glial cells to terminate migration. 
Related to Figure 1.
(A) yad122 causes over-migration of AMsh glia. Confocal images and schematic representation of AMsh glia in control and cubn-1(yad122) 
animals expressing Pf53f4.13::GFP (yadIs48). TB: pharyngeal terminal bulb. Scale bar, 10 µm. 
(B) Quantification of Migration Index (MI) in control, cubn-1(yad122), and cubn-1 (yad138) animals. MI is calculated as described in Fig. 1B. 
(C) yad122 is a null allele of cubn-1. White and grey bars show the percentage of animals with over-migration defects in one AMsh or both 
AMsh glia respectively. ok1618, gk430147, gk851178, gk787455 are predicted null alleles of cubn-1. 
(D) yad122 and yad139 caused missense mutations in cubn-1. ok1618, gk430147, gk787455 and gk851178 all caused premature stop codons. 
In Fig. B, data are represented as mean ± SEM. One-way ANOVA test. **, P<0.01; Each point represents at least 30 worms. In Fig. C, data are 
represented as mean ± SEM. Two-way ANOVA test. **, P<0.01; ns, no significant difference. Each point represents three experiments of at 































































































































































































Supplemental Figure 3, cubn-1 and lrp-1 are required for AMsh glial migration. 
Related to Figure 1.
(A) The positions of two lrp-1 RNAi probes. 
(B-C) lrp-1 cell autonomously regulates AMsh migration. Global knockdown and AMsh specific knockdown of lrp-1 cause similar AMsh 
over migration defects and did not further enhance cubn-1(lf) phenotypes (B, Migration Index; C, percentage of animals with migration 
defects). 
(D-E) (D) Quantification of Migration Index (MI) and (E) percentage of animals with AMsh migration defects in cubn-1;mrp-5 double 
mutants. 
(F) Knockdown of lrp-1 does not enhance mrp-5(lf) phenotypes. 
(G) Data show the percentage of animals with AMsh migration defects in mmcm-1, pcca-1, and metr-1 mutants. 
In Figs. B and D, data are represented as mean ± SEM. One-way ANOVA test. **, P<0.01; Each point represents at least 30 worms. In Figs. 
C, E, F and G, data are represented as mean ± SEM. Two-way ANOVA test. **, P<0.01; ns, no significant difference. Each point represents 





































































































































Supplemental Figure 4, ptp-3a and nid-1 regulates AMsh glial migration. 
Related to Figures 2, 3 and 4.
(A) yad120 causes a missense mutation in ptp-3a, and yad121 causes a missense mutation in both ptp-3a and ptp-3b. 
(B-C) Single plane confocal images show ptp-3a is expressed in AMsh cells. (B) GFP signal (left panel) shows expression of nuclear-localized 
GFP driven by the ptp-3a promoter. mCherry signal (middle panel) is from expression of mCherry::H2B under an AMsh-specific promoter 
(Pf53f4.13). The right panel shows a merged image of DIC, GFP and mCherry signal. (C) mCherry signal (left) shows expression of free 
mCherry under an AMsh-specific promoter (Pf53f4.13). GFP signal (middle panel) shows expression of PTP-3A::GFP driven by the ptp-3a 
promoter. Scale bar, 10 µm. 
(D) Data showing the relative distance between the nose tip and the center of the AMsh cell bodies in control and mutant animals. Data are 
normalized by the average distance between the nose tip and the center of the AMsh cell bodies in control animals. 
(E) Data showing the percentage of animals with AMsh migration defects for different genotypes. 
(F-G) The number of neurons visualized by DiI in D1 (F) and D7 (G) animals. 
(H) GFP signal (left panel) shows expression of NID-1::GFP driven by the nid-1 promoter. mCherry signal (middle panel) is from expression 
of mCherry::H2B under an AMsh-specific promoter (Pf53f4.13). The right panel shows a merged image of GFP and mCherry signal. All 
images are from single focal planes. Scale bar, 10 µm.  
In Figs. D, F and G data are represented as mean ± SEM. One-way ANOVA test. **, P<0.01; ns, no significant difference. Each point 
represents at least 20 worms. In Fig. E, data are represented as mean ± SEM. Two-way ANOVA test. **, P<0.01; ns, no significant difference.  




















Supplemental Figure 5, A model for regulation of AMsh glial migration by vitamin B12. 
Related to Figures 1, 2, 3 and 4.
